Back to results
CompletedPhase 2

GM1 Ganglioside Effects on Parkinson's Disease

NCT00037830

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Parkinson's Disease Research Unit, Thomas Jefferson University

Philadelphia, Pennsylvania, United States

View on ClinicalTrials.gov
GM1 Ganglioside Effects on Parkinson's Disease — TrialFind